Strategies to Optimize the Use of Erythropoietin and Iron Therapy in Oncology Patients

Transfusion. 2004 Dec;44(12 Suppl):15S-25S. doi: 10.1111/j.0041-1132.2004.04169.x.

Publication types

  • Review

MeSH terms

  • Anemia / drug therapy*
  • Anemia / etiology
  • Darbepoetin alfa
  • Epoetin Alfa
  • Erythropoiesis
  • Erythropoietin / adverse effects
  • Erythropoietin / analogs & derivatives*
  • Erythropoietin / therapeutic use*
  • Humans
  • Iron / deficiency
  • Iron / therapeutic use*
  • Neoplasms / blood
  • Neoplasms / complications*
  • Recombinant Proteins

Substances

  • Recombinant Proteins
  • Erythropoietin
  • Darbepoetin alfa
  • Epoetin Alfa
  • Iron